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In a recent study, we showed that GABA and baclofen (a GABAB receptor agonist)
inhibit caspase activation and promote axon regeneration in descending neurons of
the sea lamprey brainstem after a complete spinal cord injury (Romaus-Sanjurjo et al.,
2018a). Now, we repeated these treatments and performed 2 independent Illumina
RNA-Sequencing studies in the brainstems of control and GABA or baclofen treated
animals. GABA treated larval sea lampreys with their controls were analyzed 29 days
after a complete spinal cord injury and baclofen treated larvae with their controls
9 days after the injury. One of the most significantly downregulated genes after both
treatments was a HES gene (HESB). HES proteins are transcription factors that are
key mediators of the Notch signaling pathway and gamma-secretase activity is crucial
for the activation of this pathway. So, based on the RNA-Seq results we subsequently
treated spinal cord injured larval sea lampreys with a novel gamma-secretase inhibitor
(PF-3804014). This treatment also reduced the expression of HESB in the brainstem and
significantly enhanced the regeneration of individually identifiable descending neurons
after a complete spinal cord injury. Our results show that gamma-secretase could be a
novel target to promote axon regeneration after nervous system injuries.
Keywords: notch, gamma-secretase, axon regeneration, GABA, baclofen, RNA-Seq, lamprey, spinal cord injury
INTRODUCTION
In mammals, including humans, spinal cord injury (SCI) is a devastating event that can lead to
permanent disability. The death of neurons that are not replaced after the injury and lack of axon
regeneration of axotomized neurons are two of the main causes of permanent neurological deficits
after SCI. In striking contrast to mammals, lampreys, as other basal vertebrates, are able to recover
locomotion spontaneously after a complete SCI (Rodicio and Barreiro-Iglesias, 2012; Romaus-
Sanjurjo et al., 2018b). During recovery from a complete SCI, lampreys are able to regenerate
approximately 50% of their brainstem descending neurons and this partial axonal regeneration
is needed for recovery (Davis and McClellan, 1994; Jacobs et al., 1997; Cornide-Petronio et al.,
2011; Parker, 2017). This offers an interesting vertebrate model to find new signaling pathways
responsible for neuronal survival and axon regeneration in descending neurons after SCI.
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In a recent study, we showed that endogenous GABA
promotes axon regeneration in descending neurons of lampreys
after a complete SCI, and that GABOB (a GABA analog)
and baclofen (a GABAB receptor agonist) treatments further
promoted axon regeneration (Romaus-Sanjurjo et al., 2018a,
2019). GABA and baclofen treatments also inhibited caspase
activation in giant individually identifiable descending neurons
following the complete SCI (Romaus-Sanjurjo et al., 2018a).
Here, we repeated the GABA and baclofen treatments and carried
out 2 independent Illumina RNA sequencing (RNA-Seq) studies
in the brainstems of control non-treated animals and treated
animals. The aim of these RNA-Seq studies was to obtain gene
expression data that could reveal secondary pathways modulated
by GABAergic signaling in injured neurons and identify new
signaling pathways that could be involved in the control of
neuronal survival and axon regeneration in lampreys.
As shown below, results from these RNA-Seq experiments
revealed changes in the expression of a HES gene. HES proteins
are key mediators of the Notch signaling pathway (Engler et al.,
2018). In the developing central nervous system, Notch signaling
is mainly known for its role in neurogenesis and neuronal
differentiation (see Imayoshi and Kageyama, 2011; Engler et al.,
2018; Sagner et al., 2018), a feature that is conserved in developing
lampreys (Lara-Ramirez et al., 2019). But, interestingly, a
recent study showed that Notch signaling also inhibits axon
regeneration in worms (El Bejjani and Hammarlund, 2012;
Po et al., 2012). Whether this is also the case in vertebrates
was not known. Here, we provide evidence showing that the
pharmacological inhibition of gamma-secretase promotes axon
regeneration after a complete SCI in lampreys.
MATERIALS AND METHODS
Animals, SCI and Drug Treatments
All experiments involving animals were approved by the
Bioethics Committee at the University of Santiago de Compostela
and the Conselleriìa do Medio Rural e do Mar of the Xunta de
Galicia (license reference JLPV/IId; Spain), and were performed
in accordance with European Union and Spanish guidelines
on animal care and experimentation. Animals were deeply
anesthetized with 0.1% MS-222 (Sigma, St Louis, MO) in lamprey
Ringer solution before all experimental procedures.
Mature and developmentally stable larval sea lampreys,
Petromyzon marinus L. (n = 149; between 100 and 120 mm in
body length, 5–7 years of age), were used in this study. Larval
lampreys were collected from the river Ulla (Galicia, north-
western Spain), with permission from the Xunta de Galicia, and
maintained in aerated freshwater aquaria at 15◦C with a bed
of river sediment until their use in experimental procedures.
Larval lampreys were randomly distributed between the different
experimental groups.
SCI surgical procedures and drug treatments with GABA
and baclofen were performed as previously described (Romaus-
Sanjurjo et al., 2018a; Figure 1). Briefly, the rostral spinal
cord was exposed from the dorsal midline at the level of the
5th gill. A complete spinal cord transection was performed
with Castroviejo scissors and the spinal cord cut ends were
visualized under the stereomicroscope. After SCI, animals were
returned to individual freshwater tanks. Each injured animal
was examined 24 h after surgery to confirm that there was no
movement caudal to the lesion site. The animals were allowed
to recover in individual freshwater tanks at 19.5◦C. GABA and
baclofen were applied in the water where the animals were left
after the SCI surgical procedures (GABA at a concentration of
500 µM and baclofen at a concentration of 125 µM). GABA
treated animals and their controls were processed for RNA
extraction 29 days post-lesion (dpl) [when spontaneous axon
regrowth begins to predominate Zhang et al. (2005); Figure 1].
Baclofen treated animals and their controls were processed
for RNA extraction 9 days post-lesion [at a time in which
caspase activation begins to be detected in injured neurons
(Barreiro-Iglesias and Shifman, 2012, 2015) and axon retraction
predominates Zhang et al., 2005; Figure 1].
PF-3804014 [a novel gamma-secretase inhibitor (Lanz et al.,
2010) that has been used in recent studies to inhibit Notch
signaling (e.g., Samon et al., 2012; Wu et al., 2017); Tocris
Bioscience, United Kingdom] treatment after a complete SCI (see
previous paragraph) was done as previously described for taurine
treatments (Sobrido-Cameán et al., 2019). In these experiments,
PF-3804014 was dissolved in lamprey Ringer solution (137 mM
NaCl, 2.9 mM KCl, 2.1 mM CaCl2, 2 mM HEPES; pH 7.4) at
a concentration of 5 mM, soaked in a small piece of Gelfoam
(Pfizer; New York, NY) and placed on top of the site of injury
at the time of spinal cord transection. Control animals went
through the same surgical procedures but were only treated
with Gelfoam soaked in lamprey Ringer. Axon regeneration was
assessed 11 weeks post-lesion (wpl) in control (n = 16) and PF-
3804014 (n = 21) treated animals using Neurobiotin (Vector,
Burlingame, CA) as a retrograde tracer as previously described
(Sobrido-Cameán et al., 2019). Briefly, at 11 wpl a second
complete spinal cord transection was performed 5 mm below
the site of the original transection and Neurobiotin (Vector) was
applied in the rostral end of the transected spinal cord with the
aid of a minute pin (#000). The animals were allowed to recover
for 1 week to allow transport of the tracer from the application
point to the neuronal soma of descending neurons. Since the
original SCI was a complete spinal cord transection, only neurons
whose axons regenerated at least 5 mm below the site of injury
were labeled by the tracer. The presence of Neurobiotin in whole-
mounted brains/spinal cords was detected using Avidin-D-FITC
conjugated (Vector; 1:500).
Imaging and Quantifications
A spectral confocal microscope (model TCS-SP2; Leica, Wetzlar,
Germany) was used to acquire images of the whole-mounted
brains/spinal cords. The identity of regenerated (Neurobiotin
labeled) and non-regenerated identifiable descending neurons
was determined for each brain. Giant descending neurons are
always identifiable by their know location and big size (Jacobs
et al., 1997) regardless of the presence of the tracer. Then, we
calculated the percentage of regenerated identifiable neurons per
animal and the total number of regenerated and non-regenerated
neurons for all animals in the control and treated groups.
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FIGURE 1 | Experimental design for the RNA-Seq experiments.
For axon quantification, we scanned the rostral spinal cord
(starting at the obex) using a 20x objective. Then, we traced a
horizontal line through the middle of the spinal cord confocal
stack (Figure 2A) using the Fiji software and manually quantified
the number of axons crossing this line. To avoid missing
overlapping axons we counted through the stack of optical
sections using the counting plugin in Fiji. Only the axons that
regenerate through the site of injury (ascending or descending)
are labeled with the tracer. Note that with this preparation, we can
only quantify the coarsest axons; therefore, it is likely that more
axons actually regenerated both in control and treated animals.
The experimenter was blinded during all quantifications.
Total RNA Isolation
After the GABA or baclofen treatment periods (29 days in the
GABA experiment and 9 days in the baclofen experiment) the
brainstems of control and treated larvae were dissected out and
immediately put in RNAlater (Ambion Inc., TX, United States)
(Figure 1). RNA extraction was performed using the RNeasy
mini kit (Qiagen, Germany) with DNase treatment following
the manufacturer’s instructions. Isolated RNAs were eluted in
nuclease free water. RNA quality and quantity were evaluated in
a Bioanalyzer (Bonsai Technologies, Spain) and in a NanoDrop R©
ND-1000 spectrophotometer (NanoDrop R© Technologies Inc.,
DE, United States). RNAs were stored at −80◦C until use for
RNA-Seq.
RNA Sequencing
In the GABA experiment, 3 GABA treated and 3 control samples
(each sample containing the RNA from 4 brainstems of 4 different
animals; n = 24 in total) were sent to the Wellcome Trust Centre
for Human Genetics (Oxford, United Kingdom) for library
preparation and sequencing. RNA quality was checked again
in a Bioanalyzer (Bonsai Technologies). All samples had RNA
integrity number (RIN) of >8 (RIN measures how degraded the
RNA is on a 0–10 scale, 10 being the least degraded). mRNA
sequencing libraries were prepared from poly dT selected mRNA
using the Illumina TrueSeq Stranded mRNA Library Preparation
kit according to the manufacturer’s protocol. The average insert
size of the libraries was approximately 300 bp. A different
barcode was used for each sample to enable demultiplexing of
the sequencing data. Sequencing was conducted on an Illumina
HiSeq 4000 as 150 bp paired-end reads, yielding 23.2 to 27.8
million reads per sample.
In the baclofen experiment, 5 baclofen treated and 5 control
samples (each sample containing the RNA of 8 brainstems of
8 different animals; n = 80 animals in total) were sent to
Edinburgh Genomics (Edinburg, United Kingdom) for library
preparation and sequencing. RNA quality was checked again
in a Bioanalyzer (Bonsai Technologies). All samples had RNA
integrity number (RIN) of >7.5. mRNA sequencing libraries
were prepared from poly dT selected mRNA using the Illumina
TrueSeq Stranded mRNA Library Preparation kit according
to the manufacturer’s protocol. The average insert size of the
libraries was approximately 300 bp. A different barcode was
used for each sample to enable demultiplexing of the sequencing
data. Sequencing was conducted on an Illumina NovaSeq S1
flowcell as 100 bp paired-end reads, yielding 26.8 to 37.6 million
reads per sample.
Quality Validation and Read Mapping
Between 23.2 and 37.6 million paired-end reads per sample were
obtained (individual figures are shown in Supplementary Table
S1). Sequencing quality was evaluated using FastQC. The quality
of the baclofen experiment was significantly better than that of
the GABA experiment (Supplementary Figure S1), non-etheless
the sequencing output of both experiments showed average base
qualities above 30 (reliability of the base call, the error probability
of a quality of 30 is 0.001), except for the very last bases of the right
reads of the GABA experiment (bases 141–150). Raw paired-end
FASTQ files were quality filtered using Fastp (Chen et al., 2018)
to remove leading or trailing bases with Phred quality scores<15
(‘-q 15’), reads with length <30 base pairs (‘-l 30’), polyG tails
(‘–trim_poly_g’) and trim adaptor sequences (detected by per-
read overlap, default). Significantly more reads were trimmed
from the GABA experiment, congruent with the sequence quality
assessment. The resulting trimmed FASTQ files were aligned
against the latest lamprey genome assembly (Pmar_germline
1.0) (Smith et al., 2018) using STAR (Dobin et al., 2013) in 2-
pass mapping mode (–twopassMode Basic) with the following
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FIGURE 2 | Changes in HESB expression in the brainstem of injured animals
after drug treatments. (A) Changes in the expression of HESB in the
brainstem of injured animals after GABA or baclofen treatments (RNA-Seq).
HESB gene expression is represented as read counts normalized by DESeq’s
median of ratios, and ** represents that the differences between the two
groups are significant with false discovery rate corrected p-values between
0.01 and 0.001. Note that results are not comparable between the 2
RNA-Seq experiments. (B) Change in the expression of HESB in the
brainstem of 1 wpl animals after the PF-3804014 treatment (qPCR). HESB
expression is represented as log2 fold change in comparison to the mean of
the controls, and * represents that the differences between the two groups are
significant with p-value between 0.05 and 0.01. For both A and B, boxplots
show the median, 25th and 75th percentiles, red dots represent the mean and
whiskers extend to the most extreme data point which is no more than 1.5
times the length of the box away from the box.
parameters: 10 maximum multiple alignments allowed per
read (–outFilterMultimapNmax 10), 10 maximum mismatches
per read pair (–outFilterMismatchNmax 10), minimum and
maximum intron lengths of 20 and 1 M bp, respectively
(–alignIntronMin 20; –alignIntronMax 1000000), maximum
distance of 1 Mb between mate reads (–alignMatesGapMax
1000000) and detection of chimeric sequences with a minimum
mapped length of 20 bp (–chimSegmentMin 20; –chimScoreMin
1). The percentage of unique mapped reads ranged between 60.2
to 73.7%, with multimapping reads representing 9.3 to 26.1% and
unaligned reads 13.1 to 18.1% (Supplementary Table S1).
Transcriptome Reconstruction and Gene
Expression
StringTie (Pertea et al., 2015) with default parameters
(fr-firststrand, ‘–rf ’) was used to construct the lamprey
transcriptome from our samples using the genome alignment
files. The resulting genome-guided transcriptome has 110,157
transcripts distributed in 57,134 genes. Transcript length ranged
from 80 to 73,302 bp, with an average of 2314 bp, N50 of
5,304 bp and N90 of 987 bp. FeatureCounts (Liao et al., 2014)
was used to quantify gene expression at the gene level with
the following parameters: fragments (paired-end reads) were
counted instead of individual reads (‘-p’), only fragments with
both ends mapped were considered (‘-B’), chimeric fragments
were not considered (‘-C’), and strand specified as reversely
stranded (‘-s 2’). Statistical analyses related to differential
expression were performed using R v.3.5.21. The output
matrix was input into the R/Bioconductor package DESeq2
(Love et al., 2014).
The Benjamini-Hochberg false discovery rate (FDR) was
applied, and transcripts with corrected P-values < 0.05 were
considered differentially expressed genes. Heatmaps were drawn
using the R package ‘gplots’ v.3.01.12. Pathway analyses were
performed using Reactome (Fabregat et al., 2018), converting all
non-human gene identifiers to their human equivalents.
RNA-Seq Data Records
Raw FASTQ files for all samples were uploaded to the NCBI
Sequence Read Archive (SRA), and are publicly available
under BioProject accession numbers PRJNA561093 (GABA)
and PRJNA561123 (Baclofen). The constructed transcriptome
is available in the NCBI Transcriptome Shotgun Assembly
(TSA) database under accession GHVE00000000. Read
counts for each transcript were deposited in NCBI Gene
Expression Omnibus (GEO) and are available under accession
number GSE137860.
qPCR Experiments After PF-3804014
Treatment
4 brainstems (n = 4 animals) from control 1 wpl vehicle treated
animals and 4 brainstems (n = 4 animals) from 1 wpl PF-
3804014 treated animals were processed for qPCR analyses of
HESB (GenBank accession number: MN833804) expression.
Specific primers for targeted genes were designed using
Primer3: HESB-forward AAAGCAAAGACGGGACAGGA,
HESB-reverse GATGTCCGCCTTCTCCAGTT, GAPDH-
forward CAGATTCGTCCAGCTCCGTT, GAPDH-reverse
CCATTGTGGAGCGGATGTCA. qPCR was performed on a
Stratagene Mx3005P thermocycler (Agilent Technologies) using
Brilliant III Ultra-Fast SYBR Green QPCR Master Mix in a final
volume of 12.5 µL following the manufacturer’s protocol with
1 µL of cDNA per reaction. Primer concentration was 300 nM
and each sample was run in duplicate. The cycling parameters
were: 50◦C for 2 min, 95◦C for 10 min, followed by 40 cycles
of amplification at 95◦C for 15 s and 60◦C for 1 min. After
amplification, a dissociation step was performed raising the
temperature from 65 to 95◦C to create a melting curve and
ensure the presence of a single amplification product. qPCR data
were obtained by the MxPro software (Agilent Technologies)
1http://www.R-project.org/
2https://cran.r-project.org/web/packages/gplots/index.html
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and quantification cycle values (Cq) calculated for each replicate
and then averaged to obtain the final Cq value. HESB Cq values
were normalized using the reference gene (GAPDH), and fold
changes were calculated for each sample using the average of the
controls as reference.
Statistical Analyses
Statistical analysis was carried out using Prism 6 (GraphPad
software, La Jolla, CA). Data were presented as mean ± SEM.
Normality of the data was determined by D’Agostino–Pearson
omnibus test and all data passed the normality test. A Student’s
t-test was used to determine significant differences in the qPCR
experiment and between control and PF-3804014 treated animals
(percentage of regenerated neurons per animal and number of
regenerated axons per animal). A Fisher’s exact test was used
to determine significant differences between control and PF-
3804014 treated animals (total number of regenerated neurons).
RESULTS
RNA-Seq Differential Expression
Analyses
In previous work, we showed that both GABA and baclofen
promote axon regeneration after a complete SCI in lampreys
(Romaus-Sanjurjo et al., 2018a). Here, we aimed to identify new
genes involved in axon regeneration in lampreys that might
be regulated by GABAergic signaling. For this we carried out
2 independent RNA-Seq studies in the brainstems of injured
animals after GABA or baclofen treatments. 23 differentially
expressed genes were detected between GABA-treated and
control samples, and 82 differentially expressed genes between
baclofen-treated and control samples (Supplementary File 1). At
29 dpl, treatment with GABA induced mostly the downregulation
of genes compared to control animals (Supplementary File 1;
7 up-regulated and 16 down-regulated genes). The opposite
trend was seen at 9 dpl with baclofen, which induced the
upregulation of a higher number of genes (Supplementary
File 1; 63 upregulated and 18 downregulated genes). This
included changes in the expression of genes known to promote
axon regeneration, like the transcription factor KLF7 (increased
expression after baclofen treatment; see discussion).
A HES transcription factor [annotated as HESB in another
lamprey species Lampetra planeri (Lara-Ramirez et al., 2019)]
was the most significantly downregulated gene in response to
GABA (logFC = −0.47; Figure 2A, and Supplementary File 1);
and it was also one of the most significantly down-regulated genes
in response to baclofen (logFC = -0.44; Figure 2; Supplementary
File 1). The sea lamprey HESB transcript sequence was deposited
in GenBank under accession number MN833804. HES proteins
are key transcription factors in the Notch signaling pathway
(Ohtsuka et al., 1999). Concordantly, Reactome pathway analysis
revealed a significant enrichment of many pathways relating to
Notch signaling (FDR p-value < 0.05) amongst differentially
expressed genes after both treatments (see Supplementary File
2). This suggests that Notch signaling might play a crucial role in
axon regeneration in lampreys.
Pharmacological Inhibition of
Gamma-Secretase Promotes Axon
Regeneration After a Complete SCI
Gamma-secretase activity is crucial for the release of the Notch
intracellular domain (NICD) to activate the transcription of
target genes like the HES family of transcription factors (see
Fischer and Gessler, 2007). So, based on the RNA-Seq results
we decided to treat larval sea lampreys after a complete spinal
cord transection with the novel gamma-secretase inhibitor
PF-3804014. First, qPCR experiments showed that the PF-
3804014 treatment also caused a significant decrease in HESB
expression in the brainstem of spinal cord injured animals (1
wpl) as compared to vehicle treated controls (logFC = −0.45;
Student’s t-test, p = 0.0307; Figure 2B). At 11 wpl, the PF-
3804014 treatment significantly promoted axon regeneration of
individually identifiable descending neurons (Figure 3A; the
M1-3, I1-6, B1-B6, Mth, and Mth’ descending neurons) of
the sea lamprey (Figures 3B–D); both when looking at the
percentage of regenerated identifiable descending neurons per
animal (Student’s t-test, p = 0.0132; Figures 3B,C) or at the
total number of regenerated identifiable neurons (Fisher’s exact
test, p = 0.0032; Figures 3B,D). Moreover, the acute PF-3804014
treatment significantly increased the number of regenerated
axons (ascending or descending) in the spinal cord following a
complete SCI (Student’s t-test, p = 0.0134; Figures 3E,F). These
results show that inhibiting gamma-secretase activity acutely
after a complete spinal cord transection enhances true axon
regeneration in sea lamprey neurons.
DISCUSSION
Our 2 RNA-Seq studies in the brainstem of spinal cord injured
larval sea lampreys revealed a significant downregulation of a
HES transcription factor (HESB) and a significant enrichment
of the Notch signaling pathway after GABA and baclofen
treatments. The fact that this was detected in 2 independent
RNA-Seq studies carried out in different sequencing platforms,
using 2 different GABAergic drugs and at 2 different time
points after injury provided strong confidence on the possible
importance of this signaling pathway during regeneration.
Gamma-secretase activity is crucial for the release of NICD
to activate the transcription of target genes like the HES
family of transcription factors (see Fischer and Gessler, 2007).
Treatments with the gamma-secretase inhibitor PF-3804014 also
caused a significant decrease in the expression of HESB in
the brainstem and a significant increase in axon regeneration
after a complete SCI. Specifically, this treatment led to a
significant increase in the regeneration of individually identifiable
descending neurons of the lamprey brainstem. This is in
agreement with our previous results showing improved axon
regeneration after baclofen or GABOB treatments after SCI
in lampreys (Romaus-Sanjurjo et al., 2018a). So, the Notch
signaling pathway appears to be of crucial importance in
the regulation of axon regrowth after SCI in lampreys.
Our results also suggest that GABA signaling promotes
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FIGURE 3 | PF-3804014 promotes axon regeneration after a complete SCI. (A) Schematic drawing of a dorsal view of the sea lamprey brainstem showing the
location of giant individually identifiable descending neurons (modified from Sobrido-Cameán and Barreiro-Iglesias, 2018). The box marked “E” indicates the spinal
cord region shown in Panel E. The line used to count the number of regenerated axons in the spinal cord is also indicated. M, mesencephalon; R, rhombencephalon;
SC, spinal cord. (B) Photomicrographs of dorsal views of whole-mounted brains showing regenerated identifiable descending neurons, as identified by retrograde
tracer labeling, in control and PF-3804014 treated animals. Note the increased number of labeled (regenerated) identifiable neurons in PF-3804014 treated animals.
(C) Graph showing significant changes (asterisk) in the percentage of regenerated identifiable descending neurons per animal (controls: n = 16 animals; PF-3804014
treated: n = 21 animals) after the PF-3804014 treatment (control: 57,22 ± 4.132%; PF-3804014: 68.95 ± 2.354%). (D) Graph showing significant changes
(asterisks) in the total number of regenerated neurons after the PF-3804014 treatment (control: 292 neurons regenerated, 252 non-regenerated; PF-3804014: 444
neurons regenerated, 272 non-regenerated). (E) Photomicrographs of whole-mounted spinal cords showing regenerated axons, as identified by tracer labeling, in
control and PF-3804014 treated animals. Note the increased number of regenerated axons in PF-3804014 treated animals. The line used to count the number of
regenerated axons in the spinal cord is also indicated in white. (F) Graph showing significant changes (asterisk) in the number of regenerated axons per spinal cord
after the PF-3804014 treatment (control: 18 ± 1.588 axons, n = 15 animals; PF-3804014: 24.57 ± 1.955 axons, n = 14 animals). Rostral is up and scale bars
correspond to 100 µm.
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axon regeneration, at least partially, by inhibiting the Notch
signaling pathway.
A previous study in Caenorhabditis elegans revealed that
Notch signaling inhibits axon regeneration in identifiable
neurons of this nematode (El Bejjani and Hammarlund, 2012).
Importantly, our findings extend these results to vertebrates
and the SCI situation. As in lampreys, treatments with a
gamma-secretase inhibitor (DAPT in their case) improved axon
regeneration in worms (El Bejjani and Hammarlund, 2012).
Interestingly, gamma-secretase activity had to be inhibited right
after injury in worms to improve regeneration (El Bejjani
and Hammarlund, 2012), which coincides with our results
using also early pharmacological inhibition in lampreys. In
C. elegans, genetic manipulations showed that Notch signaling
acts autonomously in the injured neuron to prevent growth
cone formation (El Bejjani and Hammarlund, 2012). Our current
data in lampreys analyzing whole brainstems (which include
descending neurons but also other types of neurons and glial
cells) in the RNA-Seq/qPCR experiments and pharmacological
inhibition (present results) does not allow us to differentiate
between direct or indirect effects of this signaling pathway
in the regeneration of descending neurons. In future work it
would be important to study if Notch signaling acts directly
on lamprey descending neurons during regeneration or if the
positive effects of gamma-secretase inhibition come through an
indirect mechanism.
Notch1 expression increases in the rodent spinal cord after SCI
(Yamamoto et al., 2001; Chen et al., 2005), and treating human
induced pluripotent stem cell-derived neural stem/progenitor
cells with a gamma-secretase inhibitor promoted axon growth
from these cells after transplantation to the injured spinal cord
of mice (Okubo et al., 2018). So, putting together previous
data in rodents and our results in lampreys we propose that
gamma-secretase could be an interesting target to promote
axon regeneration after SCI in mammalian models. Moreover,
gamma-secretase could also serve as a target to promote other
regenerative aspects, for example gamma-secretase inhibition
promotes stem cell proliferation and generation of new motor
neurons after SCI in zebrafish (Dias et al., 2012). Future
work should test the effects of gamma-secretase inhibition in
preclinical rodent models of SCI to evaluate both positive and
negative outcomes of this treatment.
Finally, it is important to mention that our 2 RNA-Seq
studies revealed significant changes in the expression of other
genes (see Supplementary File 1), which provides a resource for
future studies on the role of these genes during regeneration.
A comparison between the GABA and baclofen RNA-Seq
experiments reveals differences in the changes of gene expression
(see Supplementary File 1). This might be related to the different
time points of analysis (29 or 9 dpl) and due to a potential
influence of GABAA receptors during GABA treatment. Changes
in gene expression after SCI in lampreys have been also observed
even at later time points when looking at the expression of specific
genes like with the HDAC1 gene (Chen et al., 2016); therefore,
new RNA-Seq studies at different time points might reveal
more genes involved in the positive effects of GABA signaling.
Regarding a possible contribution of GABAA receptors, we have
recently shown that a muscimol (a GABAA agonist) treatment
inhibits caspase activation in identifiable descending neurons
of lampreys after a complete SCI (Sobrido-Cameán et al.,
2018), which supports the possibility of an influence of GABAA
receptors during the GABA treatment.
As an example of other genes, the baclofen treatment caused
a significant increase in the expression of 2 members of the
Krüppel-like family of transcription factors (KLFs): KLF7 and
KLF10. Changes in the expression of different KLFs (including
KLF7 and KLF10) were previously detected over the course of
recovery in an RNA-Seq study after SCI in lampreys (Herman
et al., 2018). Previous work in mammalian models has revealed
a differential implication of different KLFs in the control of
axon regeneration after different types of nervous system injuries
Moore et al., 2009 (for reviews see Moore and Goldberg,
2011; Moore et al., 2011). KLF7 promotes axon regeneration
in mammals (Blackmore et al., 2012; Wang et al., 2016), which
coincides well with our results revealing increased expression
of KLF7 after baclofen treatment in lampreys with a complete
SCI. As far as we are aware, the implication of KLF10 in axon
regeneration has not yet been elucidated. Our results open the
way to study the role of these or other genes in both neuronal
survival and axon regeneration after SCI.
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